Abstract
Severe cases of SARS-CoV-2 and other pathogenic virus infections are often associated with the uncontrolled release of proinflammatory cytokines, known as a “cytokine storm.” We present a protocol for multiplex analysis of three cytokines, tumor necrosis factor-alpha (TNF-a), interleukin 6 (IL-6), and IL-10, which are typically elevated in cytokine storm events and may be used as a predictive biomarker profile of disease severity or disease course.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alijotas-Reig J, Esteve-Valverde E, Belizna C et al (2020) Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: a comprehensive review. Autoimmun Rev 19(7):102569. https://doi.org/10.1016/j.autrev.2020.102569
Tufan A, Avanoğlu Güler A, Matucci-Cerinic M (2020) COVID-19, immune system response, hyper inflammation and repurposing antirheumatic drugs. Turk J Med Sci 50(SI-1):620–632
Soy M, Keser G, Atagündüz P et al (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 39(7):2085–2094
Bindoli S, Felicetti M, Sfriso P et al (2020) The amount of cytokine-release defines different shades of Sars-Cov2 infection. Exp Biol Med (Maywood) 245(11):970–976
Rabaan AA, Al-Ahmed SH, Muhammad J et al (2021) Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (Basel) 9(5):436. https://doi.org/10.3390/vaccines9050436
Ramasamy S, Subbian S (2021) Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clin Microbiol Rev 34(3):e00299–e00220. https://doi.org/10.1128/CMR.00299-20
Peiris JS, Hui KP, Yen HL (2010) Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol 22(4):475–481
Teijaro JR (2015) The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options. Curr Top Microbiol Immunol 386:3–22
Us D (2008) Cytokine storm in avian influenza. Mikrobiyol Bul 42(2):365–380
Mares CA, Ojeda SS, Morris EG et al (2008) Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect Immun 76(7):3001–3010
de Castro IF, Guzman-Fulgencio M, Garcia-Alvarez M et al (2010) First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1. Crit Care 14(1):115. https://doi.org/10.1186/cc8846
Tisoncik JR, Korth MJ, Simmons CP et al (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76(1):16–32
Perrone LA, Plowden JK, Garcia-Sastre A et al (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4(8):e1000115. https://doi.org/10.1371/journal.ppat.1000115
Wang SY, Le TQ, Kurihara N et al (2010) Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J Infect Dis 202(7):991–1001
Cheng XW, Lu JA, Wu CL et al (2011) Three fatal cases of pandemic 2009 influenza A virus infection in Shenzhen are associated with cytokine storm. Respir Physiol Neurobiol 175(1):185–187
Sharma J, Mares CA, Li Q et al (2011) Features of sepsis caused by pulmonary infection with Francisella tularensis type A strain. Microb Pathog 51(1–2):39–47
Sharma J, Mares CA, Li Q, Morris EG, Teale JM (2011) Features of sepsis caused by pulmonary infection with Francisella tularensis type A strain. Microb Pathog 51(1–2):39–47
https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
Bhaskar S, Sinha A, Banach M et al (2020) Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper. Front Immunol 11:1648. https://doi.org/10.3389/fimmu.2020.01648
Mulchandani R, Lyngdoh T, Kakkar AK (2021) Deciphering the COVID-19 cytokine storm: systematic review and meta-analysis. Eur J Clin Investig 51(1):e13429. https://doi.org/10.1111/eci.13429
Udomsinprasert W, Jittikoon J, Sangroongruangsri S et al (2021) Circulating levels of interleukin-6 and Interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: systematic review with meta-analysis. J Clin Immunol 41(1):11–22
Morris G, Bortolasci CC, Puri BK et al (2020) The pathophysiology of SARS-CoV-2: a suggested model and therapeutic approach. Life Sci 258:118166. https://doi.org/10.1016/j.lfs.2020.118166
Stephen L (2017) Multiplex immunoassay profiling. Methods Mol Biol 1546:169–176
https://www.fresnostate.edu/csm/rimi/documents/equipment/Magpix.pdf
https://www.luminexcorp.com/download/manual-luminex-200-user-ivd-english/
Han H, Ma Q, Li C et al (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9(1):1123–1130
Kwon YJF, Toussie D, Finkelstein M et al (2020) Combining initial radiographs and clinical variables improves deep learning prognostication in patients with COVID-19 from the emergency department. Radiol Artif Intell 3(2):e200098. https://doi.org/10.1148/ryai.2020200098
Akhtar S, Ahamad MM, Rashed-Al-Mahfuz M et al (2021) Machine learning approach to predicting COVID-19 disease severity based on clinical blood test data: statistical analysis and model development. JMIR Med Inform 9(4):e25884. https://doi.org/10.2196/25884
Jiao Z, Choi JW, Halsey K et al (2021) Prognostication of patients with COVID-19 using artificial intelligence based on chest x-rays and clinical data: a retrospective study. Lancet Digit Health 3(5):e286–e294
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Guest, P.C., Abbasifard, M., Jamialahmadi, T., Majeed, M., Kesharwani, P., Sahebkar, A. (2022). Multiplex Immunoassay for Prediction of Disease Severity Associated with the Cytokine Storm in COVID-19 Cases. In: Guest, P.C. (eds) Multiplex Biomarker Techniques. Methods in Molecular Biology, vol 2511. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2395-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2395-4_18
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2394-7
Online ISBN: 978-1-0716-2395-4
eBook Packages: Springer Protocols